Focal Adhesion Kinase (FAK) Overview

The focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that distinctly co-localizes with integrins at sites of attachment to their ligands. In cells in culture, these sites are manifested as regions of close contact with the underlying substrate called focal adhesions. Attachment of integrins to their extracellular matrix ligands is a major regulatory stimulus for FAK, resulting in its tyrosine phosphorylation and enzymatic activation. Other stimuli, e.g. growth factors, neuropeptides, cytokines, mechanical stimuli, can also induce FAK phosphorylation/activation. FAK associates with a large number of enzymes, adaptor and scaffold proteins and serves both enzymatic and scaffolding roles in the transduction of signals.

FAK is organized into 4 domains. At the N-terminus is a FERM domain, which is found in a number of cytoskeletal and signaling proteins and functions to mediate protein-protein interactions. The central region of FAK contains the catalytic domain. The C-terminal domain of FAK contains two distinct regions. The C-terminal 140 amino acids comprise the focal adhesion targeting (FAT) domain, a four α-helix bundle containing binding sites for paxillin, and functions to localize FAK to focal adhesions. Between the catalytic and FAT domains is a region of undefined structure, containing two proline-rich regions that serve as ligands for the SH3 domains of several signaling proteins.

Upon activation, FAK autophosphorylates creating a docking site for the SH2 domains of a number of signaling molecules, including Src family kinases and phosphatidyl-inositol 3’-kinase. Src family kinases then promote phosphorylation of FAK on several other tyrosine residues, resulting in maximal FAK catalytic activity and creation of additional binding sites for other proteins. FAK associates with several other proteins that are tyrosine phosphorylated following integrin-dependent adhesion, p130cas and paxillin, and FAK promotes phosphorylation of these substrates.

FAK is an essential gene in the mouse. FAK has been implicated as a downstream signaling molecule that functions in the control of several integrin regulated biological processes, including cell migration, cell survival and cell proliferation. Recent studies have further defined the role of FAK and these cellular functions in a broader biological context. For example, FAK has been implicated in the control of tubule formation by endothelial cells and angiogenesis under certain circumstances in an animal model. Interesting findings also suggest that FAK may function in the control of neurite outgrowth and netrin induced axonal guidance. Dysregulation of motility, survival and proliferation is a hallmark of a number of human pathological conditions, e.g. cancer. Aberrant FAK signaling results in altered cellular phenotypes, including increased invasion, growth in soft agar, tumorigenicity and metastasis. Further, FAK is overexpressed in a number of human cancers, suggesting that FAK may play a role in the pathology of this disease.

Pyk2 is a FAK-related kinase sharing the same overall domain structure and approximately 45% sequence identity. In contrast to FAK, which is ubiquitously expressed, Pyk2 is more restricted in its expression, predominantly in epithelial cells, hematopoietic cells and neural tissue. Pyk2 is a nonessential gene as knockout mice are viable. A number of common stimuli, including growth factors, cytokines and cell adhesion regulate FAK and Pyk2. In general, FAK is more strongly activated by cell adhesion whereas Pyk2 is more strongly activated by soluble ligands. Notably, ligands that stimulate elevation of cytoplasmic calcium activate Pyk2. There are a number of common binding partners for FAK and Pyk2, e.g. Src family kinases and paxillin, suggesting some common signaling mechanisms. On the other hand, there are FAK specific ligands, e.g. DCC, and Pyk2 specific ligands, e.g. gelsolin, which play roles in distinct functions of the two kinases. Pyk2 may play important roles in macrophage and osteoclast function.

The Table below contains accepted modulators and additional information. For a list of additional products, see the "Related Products" section below.

Family Members	FAK	Pyk2
Other Names	FAK56 (D. melanogaster homolog of FAK/Pyk2) Ptk2 (mouse genomic nomenclature) p125FAK	CAKβ CADTK RAFTK FAK2 Ptk2b
Molecular Weight	119 kDa (FAKI)	115 kDa
Structural Information	1052 aa (human, mouse) 1055 aa (rat) 1053 aa (avian)	1009 aa (human, mouse, rat)
Isoforms	FAK+ (insert 3 aa after aa 903) FAK+28, 7 (insert 28 aa after aa 391 and 8 aa after aa 433) FAK+28, 6, 7 (insert 6 aa after 28 aa insert of FAK+28,7) FRNK (encodes aa 693-1052)	Pyk2s (aa 739-780 deleted) PRNK (encodes aa 781-1009)
Species	Human Mouse Rat Chicken Frog	Human Mouse Rat
Domain Organization	Proline-rich region T-Fak paxillin binding sequence contains talin binding sequence N-terminal domains bind integrin β subunit	Ferm domains
Phosphorylation Sites	Tyr397 Tyr407 Tyr576 Tyr577 Tyr861 Tyr925 Ser722 Ser840 Ser843 Ser910	Tyr402 Tyr579 Tyr580 Tyr881
Tissue Distribution	Ubiquitous All organs Lymphoid tissue Brain	Some fibroblasts Epithelial cells Brain Hematopoietic cells
Subcellular Localization	Focal adhesions Cytoplasm	In a few cases in focal adhesions or along stress fibers, most often diffusely cytosolic
Binding Partners/ Associated Proteins	Src family kinases PI3K PLCγ Grb7 Shc Grb2 SOCS p130CAS HEF1 GRAF ASAP1 Paxillin and related proteins Neogenin DCC Ezrin Trio Growth factor receptors Etk EphA1 PIAS1 Integrins FIP200 Talin p190RhoGEF Calpain	Src family kinases ASAP1 p130CAS HEF1 PRAP Pap Paxillin and related proteins Gelsolin Nir family or proteins FIP200
Upstream Activators	Integrin-dependent cell adhesion Growth factors Neuropeptides Mechanical stimuli	Growth factors Cytokines Ca2+ Nucleotides Membrane depolarization Cell adhesion
Downstream Activation	CAS Shc Grb2 PI3K	Nephorocystin PRAP
Activators	Not Known	Not Known
Inhibitors	Not Known	Not Known
Selective Activators	Not Known	Not Known
Physiological Functions	Cell motility Cell survival Cell proliferation Uptake of pathogenic bacteria Regulate actin cytoskeleton (focal adhesions)	Cell motility Uptake of pathogenic bacteria Bone resorption Regulate actin cytoskeleton (osteoclast actin ring)
Disease Relevance	Cancer	Not Known

Related Products

Sorry, an unexpected error has occurred

Network error: Failed to fetch

References

1. Arold ST. 2011. How focal adhesion kinase achieves regulation by linking ligand binding, localization and action. Current Opinion in Structural Biology. 21(6):808-813. https://doi.org/10.1016/j.sbi.2011.09.008

2. Avraham H, Park S, Schinkmann K, Avraham S. 2000. RAFTK/Pyk2-mediated cellular signalling. Cellular Signalling. 12(3):123-133. https://doi.org/10.1016/s0898-6568(99)00076-5

3. Frame MC, Patel H, Serrels B, Lietha D, Eck MJ. 2010. The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol. 11(11):802-814. https://doi.org/10.1038/nrm2996

4. Gabarra-Niecko V. 2003. 22(4):359-374. https://doi.org/10.1023/a:1023725029589

5. Gladson CL. 2003. Focal adhesion kinase in cancer. Front Biosci. 8(6):s705-714. https://doi.org/10.2741/1115

6. Infusino GA, Jacobson JR. 2012. Endothelial FAK as a therapeutic target in disease. Microvascular Research. 83(1):89-96. https://doi.org/10.1016/j.mvr.2011.09.011

7. Wee Ma W. 2011. Development of Focal Adhesion Kinase Inhibitors in Cancer Therapy. ACAMC. 11(7):638-642. https://doi.org/10.2174/187152011796817628

8. Parsons JT. 2003. Focal adhesion kinase: the first ten years. 116(8):1409-1416. https://doi.org/10.1242/jcs.00373

9. Ren X, Ming G, Xie Y, Hong Y, Sun D, Zhao Z, Feng Z, Wang Q, Shim S, Chen Z, et al. 2004. Focal adhesion kinase in netrin-1 signaling. Nat Neurosci. 7(11):1204-1212. https://doi.org/10.1038/nn1330

10. Schaller MD. 2001. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1540(1):1-21. https://doi.org/10.1016/s0167-4889(01)00123-9

11. Schaller MD. 2010. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. Journal of Cell Science. 123(7):1007-1013. https://doi.org/10.1242/jcs.045112

12. Schlaepfer DD, Mitra SK, Ilic D. 2004. Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1692(2-3):77-102. https://doi.org/10.1016/j.bbamcr.2004.04.008

13. Schlaepfer DD, Hauck CR, Sieg DJ. 1999. Signaling through focal adhesion kinase. Progress in Biophysics and Molecular Biology. 71(3-4):435-478. https://doi.org/10.1016/s0079-6107(98)00052-2

14. Sieg DJ, Hauck CR, Ilic D, Klingbeil CK, Schaefer E, Damsky CH, Schlaepfer DD. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol. 2(5):249-256. https://doi.org/10.1038/35010517

15. Hochwald SN. 2011. Focal adhesion kinase signaling and function in pancreatic cancer. Front Biosci. E3(2):750-756. https://doi.org/10.2741/e283

16. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 2004. FAK?Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol. 6(2):154-161. https://doi.org/10.1038/ncb1094

17. Feng X. 2003. PYK2 and FAK in osteoclasts. Front Biosci. 8(4):d1219-1226. https://doi.org/10.2741/1117

18. Xiong W. 2003. Roles of FAK family kinases in nervous system. Front Biosci. 8(6):s676-682. https://doi.org/10.2741/1116